immuron.com.au - IMRN Quarterly EPS earnings growth

IMRN (Immuron Inc) - company brandmark

How does the profitability of Immuron Limited (IMRN) depend on tourist flows and raw material availability? The current quarterly EPS growth rate reflects the asset's dynamics, where the 47.90 mark indicates the current state. The sale of low-capital-intensity over-the-counter products ensures stability. Growth in the customer base is supported by US military government contracts and the dietary supplement status of Travelan, which facilitates market expansion.

Immuron (IMRN) Year-over-year net earnings per share growth for the last 12 months: for the period 07/04/2022 - 11/10/2026

IMRN (Immuron Limited): analytical breakdowns and indicator data

- share price and consensus valuation forecast:
Stock Quotes immuron.com.au|IMRN - Analyst Forecast Prices
- issuer market value details:
Market Capitalization Immuron Inc|IMRN - Company Buyout Price
- balance sheet net asset value indicators:
Net Assets per Single Share Immuron|IMRN - Company Net Assets|Market Value to Book Value Ratio immuron.com.au|IMRN - Cumulative Company Assets
- debt level and financial liquidity data:
Total Debt to Equity Ratio Immuron Limited|IMRN - Long-Term Debt to Capital|Short-Term Debt to Equity immuron.com.au|IMRN - Aggregate Debt Obligations|Debt to Book Capitalization Ratio Immuron Inc|IMRN - Long-Term Debt|Company Short-Term Debt Immuron|Quick Liquidity Indicator immuron.com.au
- earnings and market multiples details:
IMRN - Final Profit|Expected Profit Immuron Limited|IMRN - Price to Earnings Ratio|Forward P/E Multiple immuron.com.au|IMRN - Growth-Adjusted Market Cap to Net Income|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Immuron Inc|IMRN - Operating profit before deduction of amortization|Net earnings per share (EPS TTM) Immuron|IMRN - Net earnings per share for the last four quarters|Year-over-year net earnings per share growth for the last 12 months immuron.com.au|IMRN - Net earnings per one share growth for the current year|Earnings growth forecast for next year Immuron Limited
Summary company analytics:Immuron Limited
Finished products of immuron.com.au

This metric measures the quarterly dynamics of earnings per share, reflecting the actual efficiency of business capitalization and the risk of overpaying for inflated expectations. By analyzing the quarterly EPS growth vector on GURU.Markets, an investor can see how the commercial success of Travelan and the immunoglobulin ecosystem of Immuron Limited (IMRN) convert into financial results, confirming the stability of the company's market positions.

Analysis of competing companies

PHAT (Phathom Pharmaceuticals, Inc.) - Year-over-year net earnings per share growth for the last 12 months|TERN: Year-over-year earnings per share growth rate for the last twelve months|IRWD (Ironwood Pharma) - Quarterly EPS earnings growth|Curanex (CURX) - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Evoke Pharma, Inc. (EVOK)|Year-over-year net earnings per share growth for the last 12 months enterothera.com ENTO|Year-over-year earnings per share growth for the last twelve months RedHill Biopharma Ltd. RDHL|PALI - Year-over-year net earnings per share growth for the last 12 months|JAGX: Year-over-year net earnings per share growth for the last 12 months|BIOR - Quarterly EPS earnings growth|Morphic Holding, Inc. (MORF) - Year-over-year earnings per share growth for the last twelve months